EpCAM-targeted CAR-T cells suppressed peritoneal metastases in mouse models, while CEA-specific CAR-T cells showed improved tumor infiltration and efficacy when combined with cytokines like IL-12 or when delivered intraperitoneally [113,114]. The gene discussed is EPCAM; the disease is neoplasm.